Bira Arumndari Nurrahma

Ms. Bira Arumndari Nurrahma

Taipei Medical University
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
STShu-Ping Tsao
Shu-Ping Tsao
BNBira Arumndari Nurrahma
Bira Arumndari Nurrahma
RKRavi Kumar
Ravi Kumar
Chieh-Hsi WuChieh-Hsi Wu
Chieh-Hsi Wu
TYTu-Hsueh Yeh
Tu-Hsueh Yeh
HHHui-Yu Huang
Hui-Yu Huang
Oxidative stress plays a key role in the degeneration of dopaminergic neurons in Parkinson’s disease (PD), which may be aggravated by concomitant PD-associated gut dysbiosis. Probiotics and prebiotics are therapeutically relevant to these conditions due to their antioxidant, anti-inflammatory, and gut microbiome modulation properties. However, the mechanisms by which probiotic/prebiotic supplementation affects antioxidant capacity and the gut microbiome in PD remains poorly characterized. In this study, we assessed the effects of a Lactobacillus salivarius AP-32 probiotic, a prebiotic (dried AP-32 culture medium supernatant), and a probiotic/prebiotic cocktail in rats with unilateral 6-hydroxydopamine (6-OHDA)-induced PD. The neuroprotective effects and levels of oxidative stress were evaluated after eight weeks of daily supplementation. Fecal microbiota composition was analyzed by fecal 16S rRNA gene sequencing. The supplements were associated with direct increases in host antioxidant enzyme activities and short-chain fatty acid production, protected dopaminergic neurons, and improved motor functions. The supplements also altered the fecal microbiota composition, and some specifically enriched commensal taxa correlated positively with superoxide dismutase, glutathione peroxidase, and catalase activity, indicating supplementation also promotes antioxidant activity via an indirect pathway. Therefore, L. salivarius AP-32 supplementation enhanced the activity of host antioxidant enzymes via direct and indirect modes of action in rats with 6-OHDA-induced PD.

2 December 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
BNBira Arumndari Nurrahma
Bira Arumndari Nurrahma
TYTu-Hsueh Yeh
Tu-Hsueh Yeh
RHRong-Hong Hsieh
Rong-Hong Hsieh
STShu-Ping Tsao
Shu-Ping Tsao
CCChia-Wen Chen
Chia-Wen Chen
HHHui-Yu Huang
Hui-Yu Huang
Oxidative stress and gut dysbiosis have been known to precede Parkinson’s disease (PD). An antioxidant-rich product, mangosteen pericarp (MP), has the ability to counterbalance excessive free radicals and the imbalanced gut microbiota composition, suggesting the MP’s capacity to delay PD progression. In this study, we explored the effects of two doses of MP extract in a unilateral 6-hydroxydopamine (6-OHDA)-induced PD rat model. We revealed that the 8-week supplementation of a low dose (LMP) and a high dose of the MP extract (HMP) improved motor function, as observed in decreased contralateral rotation, improved time spent on rod, and higher dopamine binding transporter (DAT) in the substantia nigra pars compacta (SNc). The MP extract, especially the HMP, also increased antioxidant-related gene expressions, restored muscle mitochondrial function, and remodeled fecal microbiota composition, which were followed by reduced reactive oxygen species levels in brain and inflammation in plasma. Importantly, bacterial genera Sutterella, Rothia, and Aggregatibacter, which were negatively correlated with antioxidant gene expressions, decreased in the HMP group. It is imperative to note that in addition to directly acting as an antioxidant to reduce excessive free radicals, MP extract might also increase antioxidant state by rebuilding gut microbiota, thereby enhanced anti-inflammatory capacity and restored mitochondrial function to attenuate motor deficit in 6-OHDA-induced PD-like condition. All in all, MP extract is a potential candidate for auxiliary therapy for PD.

12 March 2018 in Nutrition & Food Science
Verified
Journal Article
Closed access
BNBira Arumndari Nurrahma
Bira Arumndari Nurrahma
MSMega Febia Suryajayanti
Mega Febia Suryajayanti
ADAnggi Laksmita Dewi
Anggi Laksmita Dewi
ZKZunamilla Khairia
Zunamilla Khairia
RKRio Jati Kusuma
Rio Jati Kusuma
PSPerdana Samekto Tyasnugroho Suyoto
Perdana Samekto Tyasnugroho Suyoto
Purpose: The study aims to investigate the potency of fermented rice bran extract as anti-hypercholesterolemia product by looking at its effect on lipid profile levels and blood glucose levels in dyslipidemia model rats. Design/methodology/approach: Rice bran was fermented using Rhizopus oligosporus-contained tempeh mold extracted using distilled water. Twenty-four Sprague Dawley rats were divided into a control group and hypercholesterolemia groups. Hypercholesterolemia, also known as dyslipidemia, was induced with fructose-supplemented high-fat diet. Rats induced with dyslipidemia received three different fermented rice bran extract doses, 0 (negative) 1102.5 mg/kgBW/day (FRBE 1) and 2205 mg/kgBW/day (FRBE 2). Blood was collected before and after four weeks of treatment for lipid profile and blood glucose analysis. Findings: FRBE 2 had significantly lower total cholesterol (101.6 ± 3.3 vs 187.6 ± 3.7 mg/dL), triglyceride (83.3 ± 2.8 vs 130.7 ± 3.4 mg/dL) and LDL level (27.9 ± 1.7 vs 76.7 ± 1.5 mg/dL) but higher HDL level (64.1 ± 3.0 vs 25.5 ± 1.2 mg/dL) compared to the negative group (p < 0.001). Provision of fermented rice bran showed dose-response relationship in all blood lipid markers. Originality/value: This study was the first to investigate the effectivity of Rhizopus sp.-fermented rice bran extract to improve glucose and lipid profile.

1 March 2026 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
SSShubh Saraswat
Shubh Saraswat
BNBira Arumndari Nurrahma
Bira Arumndari Nurrahma
PKPhilip A Kern
Philip A Kern
BNBarbara S Nikolajczyk
Barbara S Nikolajczyk
XZXiaohua Douglas Zhang
Xiaohua Douglas Zhang
Background: Multiplex cytokine assays are widely used for biomarker discovery and disease profiling, but most existing web tools are optimized for metabolomics and require substantial data reformatting. A reproducible, end-to-end computational platform tailored to cytokine analysis is needed. Methods: We developed CytokineProfile, a web-based analytic tool that accepts standard tabular formats and guides users through data preview, quality control, missing-value handling, and filtering. Analytical modules include exploratory visualization (boxplots, correlation matrices, volcano plots, and dual-flashlight plots combining log fold change with strictly standardized mean difference), univariate tests (analysis of variance and normality-informed 2-sample tests), multivariate modeling (principal component analysis, sparse partial least squares discriminant analysis, and multilevel/multivariate integration variants), and machine-learning classifiers (extreme gradient boosting and random forest) with feature-importance outputs. Results: In a case study using anti-CD3/anti-CD28-stimulated peripheral blood mononuclear cell cytokine profiles from subjects with prediabetes at 20 and 72 h (33 samples per time point), CytokineProfile supported same-dataset comparison with MetaboAnalyst and CytokineExplore, generated consistent group separation in supervised analyses, and provided complementary volcano, dual-flashlight, and machine-learning-based feature results. Benchmarking on datasets up to 1,000 samples and 100 cytokines showed practical runtime and memory usage for representative workflows. Conclusion: CytokineProfile provides a reproducible, user-friendly platform integrating quality control, statistical analysis, visualization, and machine learning. The tool streamlines cytokine biomarker discovery and interpretation, supporting rigorous analysis of complex datasets.